Treeway Competitors and Similar CompaniesClear all

Treeway's competitors and similar companies include Cardiorentis, AdoRx Therapeutics and Temisis Therapeutics.
Treeway
Treeway
Treeway is a clinical-stage biotechnology company.
Cardiorentis
Cardiorentis
Cardiorentis is a biopharmaceutical company, developing drug therapies for the treatment of acute heart failure and related cardiovascular diseases.
AdoRx Therapeutics
AdoRx Therapeutics
AdoRx Therapeutics is a company that pursues the discovery of new therapeutics for cancer based on modulation of the adenosine pathway.
Temisis Therapeutics
Temisis Therapeutics
Temisis Therapeutics is a therapeutic company focusing on the development of small-molecule assets for the treatment of unmet needs in pathologies possessing an inflammatory component.
Type
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Tilburg, NL HQ
Locations
Zug, CH HQ
Freienbach, CH
Locations
Edinburgh, GB HQ
Locations
Vandœuvre-lès-Nancy, FR HQ
Employees
Employees
12
Employees
N/A
Employees
N/A
Employees
2

Funding

Latest funding round
Latest funding round
$ 55.8k (about 11 years ago)
Latest funding round
N/A
Latest funding round
$ 10m (about 8 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 55.8k
Total funding raised
$ 118.5m
Total funding raised
$ 10m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Cardiorentis
HQ
Zug, CH

Cardiorentis is a biopharmaceutical company, developing drug therapies for the treatment of acute heart failure and related cardiovascular diseases.

View company
AdoRx Therapeutics
HQ
Edinburgh, GB

AdoRx Therapeutics is a company that pursues the discovery of new therapeutics for cancer based on modulation of the adenosine pathway.

View company
Temisis Therapeutics
HQ
Vandœuvre-lès-Nancy, FR
Employees
2

Temisis Therapeutics is a therapeutic company focusing on the development of small-molecule assets for the treatment of unmet needs in pathologies possessing an inflammatory component.

View company